Inhibition of Estrogen Receptor Signaling as a Strategy for Radiosensitization of ER plus Breast Cancers

被引：0
|
作者：
Michmerhuizen, A. R. [1 ]
Pesch, A. [1 ]
Schwartz, R. [1 ]
Wilder-Romans, K. [1 ]
Liu, M. [1 ]
Harold, A. [1 ]
Azaria, R. [1 ]
Hayes, D. [1 ]
Rae, J. [1 ]
Pierce, L. J. [2 ]
Schmidt, D. R. [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2507
引用
收藏
页码：E253 / E253
页数：1
相关论文
共 50 条
  • [31] Minireview: Inflammation: An Instigator of More Aggressive Estrogen Receptor (ER) Positive Breast Cancers
    Baumgarten, Sarah C.
    Frasor, Jonna
    MOLECULAR ENDOCRINOLOGY, 2012, 26 (03) : 360 - 371
  • [32] Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers
    Floris H. Groenendijk
    Tina Treece
    Erin Yoder
    Paul Baron
    Peter Beitsch
    William Audeh
    Winand N. M. Dinjens
    Rene Bernards
    Pat Whitworth
    npj Breast Cancer, 5
  • [33] Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers
    Groenendijk, Floris H.
    Treece, Tina
    Yoder, Erin
    Baron, Paul
    Beitsch, Peter
    Audeh, William
    Dinjens, Winand N. M.
    Bernards, Rene
    Whitworth, Pat
    NPJ BREAST CANCER, 2019, 5 (1)
  • [34] Estrogen receptor negative breast cancers express estrogen receptor mRNA
    McMahon, C
    Alkarain, A
    Seth, A
    Slingerland, J
    ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) : S50 - S50
  • [35] Estrogen receptor negative breast cancers express estrogen receptor mRNA
    C. McMahon
    A. Alkarain
    A. Seth
    J. Slingerland
    Annals of Surgical Oncology, 2004, 11 : S50 - S50
  • [36] Estrogen receptor negative breast cancers express estrogen receptor mRNA
    Arnaout, A.
    McMahon, C.
    Seth, A.
    Slingerland, J.
    EJC SUPPLEMENTS, 2004, 2 (03): : 173 - 173
  • [37] Assessment of ESR1 and ERBB2 mutations in estrogen receptor positive (ER plus ) metastatic breast cancers (MBC).
    Basu, Gargi D.
    White, Tracey
    LoBello, Janine R.
    Kurdoglu, Ahmet
    Trent, Jeffrey M.
    Halbert, Matthew J.
    Royce, Thomas
    O'Shaughnessy, Joyce
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [38] Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
    Girgert, Rainer
    Emons, Guenter
    Gruendker, Carsten
    FRONTIERS IN ENDOCRINOLOGY, 2019, 9
  • [39] Chemoproteomic evaluation of PROTACs targeting estrogen receptor alpha for ER plus breast cancer
    Sandusky, Zachary
    Brown, Myles
    CANCER RESEARCH, 2024, 84 (06)
  • [40] Dissecting mechanisms of CART signalling through the estrogen receptor in ER plus breast cancer
    Mooney, Brian
    Das, Sudipto
    Klinger, Rut
    Gallagher, William
    O'Connor, Darran
    CANCER RESEARCH, 2016, 76
12345